ストックスクリーナーアプリを入手
32.34
0.77%
-0.25
アフターアワーズ：
32.34
前日終値:
$32.59
開ける：
$32.77
24時間の取引高:
593.43K
Relative Volume:
0.65
時価総額：
$1.87B
収益：
$868.45M
当期純損益:
$158.69M
株価収益率:
11.94
EPS:
2.7087
ネットキャッシュフロー:
$328.64M
1週間 パフォーマンス:
+3.79%
1か月 パフォーマンス:
+16.58%
6か月 パフォーマンス:
+3.16%
1年 パフォーマンス:
+7.94%
1日の値動き範囲:
$32.22
$32.89
1週間の範囲:
$30.76
$33.00
52週間の値動き範囲:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
32.34 | 1.89B | 868.45M | 158.69M | 328.64M | 2.7087 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-23 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2026-02-23 | ダウングレード | Truist | Buy → Hold |
| 2026-02-11 | 再開されました | UBS | Neutral |
| 2025-07-21 | 開始されました | Truist | Buy |
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Wall Street analysts think Harmony Biosciences (HRMY) could surge 34.81%: Read this before placing a bet - MSN
Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice - Yahoo! Finance Canada
HRMY or ARGX: Which Is the Better Value Stock Right Now? - Yahoo Finance
Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a Bet - Yahoo Finance UK
Harmony Biosciences Schedules First-Quarter Earnings Call for May 7 - MyChesCo
CX Institutional Increases Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Capital Management Corp VA Sells 41,191 Shares of Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
HRMY stock on track for best intraday gains in 18 months — what did Mizuho analysts say? - MSN
Price-Driven Insight from (HRMY) for Rule-Based Strategy - Stock Traders Daily
Earnings Preview: HRMY to Report Financial Results Pre-market on May 07 - Moomoo
M3Sixty Small Cap Growth Fund's Harmony Biosciences Holdings Inc(HRMY) Holding History - GuruFocus
Harmony Bio spikes after new Wakix patent litigation - MSN
Harmony Biosciences (HRMY) Projected to Post Quarterly Earnings on Thursday - MarketBeat
A Look At Harmony Biosciences (HRMY) Valuation After CFO Appointment And Reaffirmed 2026 Revenue Outlook - Sahm
Top 5 US Stocks To Buy In May 2026 - Investing.com
Q3 Earnings Estimate for HRMY Issued By HC Wainwright - MarketBeat
Harmony Biosciences Appoints Glenn Reicin as CFO, Reaffirms Outlook - MyChesCo
Assessing Harmony Biosciences (HRMY) Valuation After Recent Share Price Momentum And Pipeline Expectations - Yahoo Finance
H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Harmony Biosciences stock rating on IP litigation outlook - Investing.com Australia
Research Analysts Issue Forecasts for HRMY Q1 Earnings - MarketBeat
Why Harmony Biosciences (HRMY) Reaffirmed 2026 Revenue Guidance and Hired a Markets-Focused CFO - Yahoo Finance
Harmony Biosciences (HRMY) Attracts Buy Rating Amid IP Litigatio - GuruFocus
Harmony Bio granted FDA label expansion for Wakix in children with narcolepsy - MSN
Harmony Biosciences Holdings, Inc. (HRMY) Latest Stock News & Headlines - Yahoo Finance
Press Release: Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - Business Wire
Analysts Are Bullish on These Healthcare Stocks: Guardant Health (GH), Crescent Biopharma (CBIO) - The Globe and Mail
Ruffer LLP Purchases Shares of 40,993 Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Legend Biotech (LEGN) moves 18.4% higher: Will this strength last? - MSN
Oppenheimer raises Harmony Biosciences stock price target on patent strength - Investing.com
Harmony Biosciences (HRMY) Is Up 9.7% After New CFO Hire And Reiterated 2026 Guidance – Has The Bull Case Changed? - simplywall.st
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $72 at Oppenheimer - StreetInsider
HRMY.O - Reuters
HRMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):